Showing 2591-2600 of 7016 results for "".
Ketamine to Treat Alcoholism?
https://reachmd.com/programs/clinicians-roundtable/ketamine-to-treat-alcoholism/3779/Ketamine is a schedule III drug with a long history as an anesthetic. It also is a well-known club drug in the party circuit. How can it be that it has anti-addictive properties and might it be useful to treat alcoholism? Dr. Stephen Ross, director of the Division of Alcoholism & Drug Abuse at BRaltegravir Therapy for Multi-Drug Resistant HIV
https://reachmd.com/programs/clinicians-roundtable/raltegravir-therapy-for-multi-drug-resistant-hiv/3521/In the quest to find therapies for multi-drug resistant HIV, researchers have zeroed in on raltegravir. The latest data indicates this potent agent provides the highest reported virologic suppression rate among multi-drug resistant patients. Is raltegravir proving more effective than antiretroviralsEvidence-Based Guidelines for Managing Acne: Updates from AAD
https://reachmd.com/programs/clinicians-roundtable/evidence-based-guidelines-for-managing-acne-updates-from-aad/30057/The 2024 AAD guidelines provide updates and evidence-based recommendations for treating acne to improve patient outcomes. Here’s an overview.Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
https://reachmd.com/programs/cme/new-data-hypercortisolism-prevalence-difficult-to-control-metabolic-conditions/50066/Recent data from 2024 and 2025 shed light on the prevalence of Cushing syndrome (hypercortisolism) among individuals with hard-to-control metabolic conditions. Now, 2026 brings even more up-to-date insights in this area. Join our expert faculty as they review the latest evidence and discuss its implRetinal Vein Occlusion as a Predictor of Stroke
https://reachmd.com/programs/eye-on-ocular-health/retinal-vein-occlusion-as-a-predictor-of-stroke/37661/Case-Based Management of AAV
https://reachmd.com/programs/cme/case-based-management-of-aav/14963/Given the unmet needs in AAV treatment with glucocorticoids, there may be a role for complement receptor inhibition. Hear more from our experts!Catching Demodex in the Act
https://reachmd.com/programs/cme/Catching-Demodex-in-the-Act/56703/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
https://reachmd.com/programs/neurofrontiers/program-name/36462/Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
https://reachmd.com/programs/heart-matters/translating-patisirans-6-minute-walk-test-gains-into-real-life-impact-in-attr-cm/36136/Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
https://reachmd.com/programs/cme/looking-ahead-integrating-cdh6-targeted-therapies-into-ovarian-cancer-treatment-paradigms/37866/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer